Jill Lin

Jill Lin is a biotechnology professional and analytics leader with over 15 years of experience in oncology and neuroscience. They have held key positions at various companies, including Genentech, Jazz Pharmaceuticals, and Seagen, where they managed global insights, market research, and commercial analytics. Jill has launched over 15 new drugs and line extensions in the past decade and has a strong academic background with degrees from the University of Chicago, Stanford University, and the University of Washington. Currently, they are the Head of Market Research Insights for the Oncology Commercial Portfolio at Pfizer.